Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

IE0005711209
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000CTSZQ6
ICLR
ICON PLC
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Diagnostics & Research · THEMEFOLIO: $HLTH
NAME
ICON PLC
ISIN
IE0005711209
TICKER
ICLR
MIC
XNAS
REUTERS
ICLR.OQ
BLOOMBERG
ICLR US
Tue, 23.06.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the first quarter ended March 31, 2026. CEO, Mr. Barry Balfe commented, “ICON maintained strong commercial momentum in quarter one, delivering net bookings of $2.9 billion, and a net book-to-bill of 1.42, driven by robust gross award...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 22.06.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR) today announced that it has selected Microsoft as a preferred technology partner – further advancing ICON’s previously announced plan to invest in digital innovation and AI over the next three years. This partnership incorporates an enterprise-wide deployment of Microsoft 365 Copilot along with an enterprise-grade cloud, da...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 17.06.2026       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization, today announced that it will release its financial results for the first quarter 2026 after the market closes on Tuesday, June 23, 2026. The company will hold a conference call and webcast to discuss its financial results and performance on Wednesday, June 24, 2026 at 8:00am...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.05.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the fourth quarter and full year 2025, and announced the outcome of its investigation by the Audit Committee of the Board of Directors into certain accounting practices. CEO, Mr. Barry Balfe commented, “ICON demonstrated continued co...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 26.05.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market closes on Wednesday, May 27, 2026. The Company will hold a conference call and webcast to discuss its financial results and performance on Thursday, May 2...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 13.05.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas. These new, purpose-built clinics w...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.04.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that the Audit Committee of the Board of Directors has completed its investigation into certain of the Company’s accounting practices and controls. The Company reaffirmed that there was no impact on customers, operations or cash flow. Consistent with the p...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 24.03.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, and Advarra, the market leader in regulatory reviews and a leading provider of connected, intelligence-powered research technology, have entered a definitive partnership agreement to introduce a new ‘research-ready,’ connected site network model for clinical trials. The par...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 16.03.2026       Icon Plc
IE0005711209

New York, New York--(Newsfile Corp. - March 16, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company (NASDAQ: ICLR) ("ICON Public Limited Company") concerning potential violations of the federal securities laws.The magnitude of the single-day decline wiped out billions of dollars of...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 09.03.2026       Icon Plc
IE0005711209

New York, New York--(Newsfile Corp. - March 9, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws.The magnitude of the single-day decline wiped out billions of dollars of...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 05.03.2026       Icon Plc
IE0005711209

NEW YORK, March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.03.2026       Icon Plc
IE0005711209

New York, New York--(Newsfile Corp. - March 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws.The magnitude of the single-day decline wiped out billions of dollars of...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 26.02.2026       Icon Plc
IE0005711209

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 25.02.2026       Icon Plc
IE0005711209

The law firm of Kirby McInerney LLP continues its investigation on behalf of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ:ICLR) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION]...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.02.2026       Icon Plc
IE0005711209

New York, New York--(Newsfile Corp. - February 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws.The magnitude of the single-day decline wiped out billions of dollars...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 20.02.2026       Icon Plc
IE0005711209

NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICON plc ("ICON" or the "Company") (NASDAQ: ICLR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 20.02.2026       Icon Plc
IE0005711209

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or faile...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.02.2026       Icon Plc
IE0005711209

(NASDAQ: ICLR)NEW YORK, Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating ICON plc (NASDAQ: ICLR) following the company's disclosure on February 12, 2026, that an internal accounting investigation uncovered preliminary evidence that revenue for fiscal years 2023 and 2024 may have been overstated by up to two percent each yea...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Icon Plc
IE0005711209

New York, New York--(Newsfile Corp. - February 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ICON Public Limited Company ("ICON Public Limited Company") (NASDAQ: ICLR) concerning potential violations of the federal securities laws.The magnitude of the single-day decline wiped out billions of dollars...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.02.2026       Icon Plc
IE0005711209

Boston, Massachusetts--(Newsfile Corp. - February 17, 2026) - Block & Leviton is investigating ICON plc (NASDAQ: ICLR) for potential securities law violations. Investors who have lost money in their ICON plc investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.c...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Sat, 14.02.2026       Icon Plc
IE0005711209

The law firm of Kirby McInerney LLP is investigating potential claims against ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ:ICLR). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 13.02.2026       Icon Plc
IE0005711209

Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONE...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 13.02.2026       Icon Plc
IE0005711209

Law Offices of Howard G. Smith announces an investigation on behalf of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ICON PUBLIC LIMITED COMPANY (ICLR), CONTACT THE LAW OFFICES OF HOWARD G. SMITH...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 13.02.2026       Icon Plc
IE0005711209

ICLR Investors with Losses Encouraged to Contact Hagens BermanSAN FRANCISCO, Feb. 13, 2026 /PRNewswire/ -- Investors in ICON plc (NASDAQ: ICLR) saw the price of their shares drop about 49% during trading on February 12, 2026, after the company disclosed its investigation into the propriety of its revenue recognition in fiscal years 2023 through 20...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.02.2026       Icon Plc
IE0005711209

The Law Offices of Frank R. Cruz announces an investigation of ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ: ICLR) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ICON PUBLIC LIMITED COMPANY (ICLR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PU...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.02.2026       Icon Plc
IE0005711209

MILWAUKEE, Feb. 12, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against ICON (NASDAQ: ICLR). The investigation results from inaccurate statements ICON may have made regarding its financial statements, business operations and prospects....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.02.2026       Icon Plc
IE0005711209

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ICON plc (NASDAQ: ICLR) resulting from allegations that ICON plc may have issued materially misleading business information to the investing public. So What: If you purchased ICON securities you may be en...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 12.02.2026       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) today announced that it intends to release its fourth quarter and full year 2025 earnings results on or prior to April 30, 2026. The Company also announced an ongoing internal investigation initiated by the Audit Committee of the Board of Directors in late October 2025 into certain of the Company’s accounting practices and...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.01.2026       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR) today announced a significant expansion of oncology research capabilities within its Accellacare Site Network through the opening of the Brian Moran Cancer Institute at Duly Health and Care in Illinois. The new institute strengthens Accellacare’s ability to support oncology clinical trials and broaden access to innovative...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 09.12.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market. In total, both surveys captured...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.12.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup. The findings underscore the need for a site-centric, collaborative approach to overcome bottlenecks and enhance trial activation timelines. The sur...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 12.11.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that Mr. Barry Balfe, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc, will present at the Jefferies London Healthcare Conference on Wednesday, November 19, 2025 at 9:00 am GMT. Any changes to this event and links to the live webcast (where available)...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.10.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the third quarter ended September 30, 2025. CEO, Mr. Barry Balfe commented, “ICON’s results in quarter three were reflective of broad market conditions, as we continued to partner with customers to navigate an uncertain environment....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 24.09.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation, today announced that it will release its financial results for the third quarter 2025 after the market closes on Wednesday, October 22, 2025. The company will hold a conference call and webcast to discuss its financial results and performance on Thursday, October 23, 2025 at...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Thu, 04.09.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board has appointed Mr. Barry Balfe, ICON’s Chief Operating Officer, to succeed Dr. Cutler as Chief Executive Officer effective 1 October 2025. Mr. Balfe...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 02.09.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Barry Balfe, COO of ICON plc, will present at the Baird 2025 Global Healthcare Conference on Wednesday, September 10, 2025 at 1:25 pm ET and Dr. Steve Cutler, CEO of ICON plc, will participate at the Deutsche Bank 20...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.07.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 22, 2025 were duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 11, 2025...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.07.2025       Icon Plc
IE0005711209

ICON plc (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today reported its financial results for the second quarter ended June 30, 2025. CEO, Dr. Steve Cutler commented, “ICON made solid progress in quarter two despite the continuing challenges within the clinical development and macro-economic...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 16.07.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clinical trials in a benchmarking report from the independent pharmaceutical market research company Industry Standard Research (ISR). ICON outpaced the a...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 07.07.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2025 with a number of business awards, recognising the company’s leadership position in the clinical research industry, cutting-edge innovation, its efforts in inclusion and sustainability, and as an employer...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.06.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that it will release its financial results for the second quarter 2025 after the market closes on Wednesday, July 23, 2025. The company will hold a conference call and webcast to discuss its financial results and performance...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.06.2025       Icon Plc
IE0005711209

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company (“ICON” or “the Company”) (NASDAQ: ICLR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission....
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.06.2025       Icon Plc
IE0005711209

LOS ANGELES, June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 02.06.2025       Icon Plc
IE0005711209

LOS ANGELES, June 2, 2025 /PRNewswire/ --  The DJS Law Group reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR) for violations of the federal securities laws. Sh...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 28.05.2025       Icon Plc
IE0005711209

LOS ANGELES, May 28, 2025 /PRNewswire/ --  The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.05.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth Stock Conference on Wednesday, June 4, 2025 at 10.40 am CT. Any changes to this event and links to the live webcast (where availab...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 23.05.2025       Icon Plc
IE0005711209

LOS ANGELES, May 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.05.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering on its environmental, social and governance (ESG) goals, as delivered through its ICON Cares program. In recognition of its efforts in 2024, ICON r...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Fri, 16.05.2025       Icon Plc
IE0005711209

LOS ANGELES, May 16, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company ("ICON" or "the Company") (NASDAQ: ICLR)  for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink
Wed, 07.05.2025       Icon Plc
IE0005711209

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studi...
Read more
Icon Plc
Technical Analysis Termsheets Terminal
Permalink